Tetraphase Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.
Note: Tetraphase Pharmaceuticals's revenues are gauged from an analysis of company filings.
Tetraphase Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
January 28, 2020
Complete list of funding rounds and total amounts in the Company Report
Trademark applications show the products and services that Tetraphase Pharmaceuticals is developing and marketing.
Tetraphase Pharmaceuticals doesn't have any recent trademark applications, indicating Tetraphase Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
XYRAVIO Pharmaceutical preparations, namely, antibiotics; all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of, the central nervous system, sleep disorders, cognitive disorders, fibromyalgia, insomnia, narcolepsy, and neurological or psychiatric diseases or disorders
Determine whether Tetraphase Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Tetraphase Pharmaceuticals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Tetraphase Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Tetraphase Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Tetraphase Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Tetraphase Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.